Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03518216 · ClinicalTrials.gov registry record · NA

Neural Mechanisms of Treatment Response to ADAPT

A NA study of Anxiety and Functional Abdominal Pain Syndrome, sponsored by Michigan State University.

Completed
Registry status
NA
Development phase
49
Enrollment target
1
Study location

NCT03518216 is a NA study of Anxiety and Functional Abdominal Pain Syndrome that has completed, run by Michigan State University. The registered enrollment target is 49 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03518216, a NA study of Anxiety and Functional Abdominal Pain Syndrome, has completed, sponsored by Michigan State University.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target
1
Study location

Study Summary

Complex functional abdominal pain disorders (FAPD) with co-occurring anxiety are highly prevalent in children, can be very disabling, and are not responsive to currently available treatments. This research aims to better understand the neural mechanisms involved in a promising nonpharmacological treatment for FAPD to ultimately guide the development of more targeted treatment approaches for afflicted youth.

Interventions

  • BEHAVIORAL ADAPT

Study Locations (1)

Michigan

  • Michigan State University - Grand Rapids

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2018-07-03
Est. Completion 2024-12-31
Phase NA

Sponsor

Michigan State University

120 total trials

What the Registry Record Tells You About NCT03518216

The ClinicalTrials.gov registry entry for NCT03518216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which ADAPT is the first listed.

NCT03518216 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03518216 about?

NCT03518216 is a clinical study titled "Neural Mechanisms of Treatment Response to ADAPT". Complex functional abdominal pain disorders (FAPD) with co-occurring anxiety are highly prevalent in children, can be very disabling, and are not responsive to currently available treatments. This research aims to better understand the neural mechanisms involved in a promising nonpharmacological tre...

What is the current status of trial NCT03518216?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2018-07-03. Estimated completion is 2024-12-31.

What conditions does trial NCT03518216 study?

This clinical trial studies the following conditions: Anxiety, Functional Abdominal Pain Syndrome.

What interventions are being tested in trial NCT03518216?

The interventions under investigation include: ADAPT (BEHAVIORAL).

Who is sponsoring clinical trial NCT03518216?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03518216 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.